You are here

Eli Lilly

Eli Lilly's Osteoporosis Drug Stopped in Its Tracks

Seeking Alpha

Mon, 08/24/09 - 08:30 pm

Lilly to Pay $15.75 Million to West Virginia in Zyprexa Suit

Bloomberg

Thu, 08/20/09 - 04:09 pm

Tough Decisions on Osteoporosis Drugs

Businessweek

Thu, 08/20/09 - 06:19 am

Amgen's Climbing Up the Ladder

Motley Fool

Wed, 08/19/09 - 03:51 pm

Bristol-Myers Squibb

Drug stocks mixed; Lilly falls on drug setback

Marketwatch

Wed, 08/19/09 - 09:59 am

Lilly not submitting osteo drug data to FDA

Marketwatch

Wed, 08/19/09 - 06:11 am

Court invalidates 1 of Lilly's Gemzar patents

Yahoo/AP

Tue, 08/18/09 - 08:04 am

United Therapeutics' Growth Driven By Approval Of Two New Treatments

Yahoo/Investors Business Daily

Tue, 08/18/09 - 06:26 am

United Therapeutics

Gilead Sciences

Amgen Gains Ammo Against Erbitux

Forbes

Mon, 08/17/09 - 07:47 pm

Erbitux’s marginal clinical benefit in lung cancer could prompt second look from regulators

FT.com

Thu, 08/13/09 - 09:05 pm

Nanosphere, Eli Lilly collaborating on genetic tests for use in drug development

Yahoo/AP

Tue, 08/11/09 - 08:49 am

Pharma: Goldman Bullish On Merck; Bearish On Lilly

Barron's

Mon, 08/10/09 - 07:49 pm

Lilly leads drug stocks south

Marketwatch

Mon, 08/10/09 - 09:47 am

Eli Lilly says new blood thinner Effient reaches US market

Yahoo/AP

Wed, 08/5/09 - 11:04 am

Lilly centers sales around staff with "deep therapeutic expertise"

Pharma Times, UK

Wed, 08/5/09 - 08:29 am

Lilly makes buyout offer to 4,000 sales reps

Yahoo/AP

Tue, 08/4/09 - 05:20 pm

Eli Lilly’s Payments to Doctors Revealed

WSJ Online

Fri, 07/31/09 - 02:53 pm

physician payments

The Effient Launch: Cracking the Door to Primary-Care Marketing

InVivo

Fri, 07/31/09 - 11:40 am

Lilly settles Gemzar patent suits with ScinoPharm

Forbes

Thu, 07/30/09 - 09:12 am

Lilly, BioMS scrap MS drug after trial fails

Reuters

Tue, 07/28/09 - 09:22 am

multiple sclerosis

Pages